Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB — Stella
Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(11 sites)
Mozambique
Hospital Geral da Polana Caniço, Maputo
Philippines
De La Salle Health Sciences Institute- DLSUMC, Dasmariñas
Lung Center Of The Philippines, Quezon City
Silang Specialists Medical Center, San Vincent Silang
Russia
First Moscow State Medical University n.a. I.M. Sechenov, Moscow
South Africa
THINK: Tuberculosis & HIV Investigative Network, Durban
Sizwe Tropical Diseases Hospital, Johannesburg
Wits Health Consortium, Port Elizabeth
Desmond Tutu TB Centre, Stellenboch
Uganda
Makerere University Lung Institute, Kampala
Ukraine
State Institute Of Phthisiology And Pulmonology N.A. F.G. Yanovskiy Of Ams Ukraine, Kiev